Literature DB >> 23250315

[The prevalence of abnormal cytology and inflammation and their association with risk factors for uterine cervical neoplasms in Cauca, Colombia].

Yaliana Tafurt-Cardona1, Claudia P Acosta-Astaiza, Carlos H Sierra-Torres.   

Abstract

OBJECTIVES: Establishing the prevalence of abnormal and inflammation cytology reports and its association with risks factors for uterine cervical neoplasms amongst females from the Cauca department in Colombia.
METHODOLOGY: After signing a consent-form, females were interviewed using a questionnaire to collect socio-demographic and clinical data, including reproductive history, sexual activity, cytology history and smoking habits. Cytology was then taken for analysis and classification according to the 2001 Bethesda System. A total of 1,735 females were recruited for the study.
RESULTS: According to the cytology report, 1061 women had normal cytology (61 %), 36 abnormal cytology (2 %) and 638 reactive cellular changes associated with inflammation (37 %). The results indicated that having sexual intercourse at an early age, multiparity, using hormonal contraceptives and not having annual cytology screening were associated with abnormal cytology reports.
CONCLUSIONS: These results provided valuable information for public health institutions for developing better screening programmes to prevent risks of uterine cervical neoplasms amongst females from our region and throughout Colombia.

Entities:  

Mesh:

Year:  2012        PMID: 23250315     DOI: 10.1590/s0124-00642012000100005

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  2 in total

1.  Associated factors with cervical pre-malignant lesions among the married fisher women community at Sadras, Tamil Nadu.

Authors:  Sornam Ganesan; Vasantha N Subbiah; Jothi Clara J Michael
Journal:  Asia Pac J Oncol Nurs       Date:  2015 Jan-Mar

2.  Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting?

Authors:  Leonard Ogbonna Ajah; Chibuike Ogwuegbu Chigbu; Benjamin Chukwuma Ozumba; Theophilus Chimezie Oguanuo; Paul Olisaemeka Ezeonu
Journal:  Onco Targets Ther       Date:  2015-07-27       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.